AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00%

EPI EPIMINDER FPO [EPI]

Healthcare · Medical Devices · website
$0.34
52wk 0.25 – 1.49
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About EPIMINDER FPO [EPI]

Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company's Minder system comprises Minder implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder app that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder cloud for processing; and Minder cloud, a secure, online portal which allows healthcare professionals to download patient data. Epi-Minder Pty Ltd was incorporated in 2017 and is based in Melbourne, Australia.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$72,585
P/E (trailing)
P/E (forward)
-1.96
EPS (trailing)
-0.20
Dividend yield
Payout ratio
0.0%
Beta
EV / EBITDA
2.09
Price / Book
0.29
ROE
Operating margin
-3,851.3%
Net margin
0.0%
Total cash
$89.50M
Total debt
$0
Current ratio
23.21
Debt / Equity
Free cash flow
Avg volume
180,152
Latest annual results (FY ending 30 Jun 2025)
  • Revenue
  • Gross profit
  • Operating income-$28.59M
  • Net income-$34.51M
  • Diluted EPS
  • Free cash flow
  • Net debt-$116.95M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $59.53B 14.0
RMD $43.89B 20.4
SIG $34.28B 59.4
FPH $20.25B 52.2
PME $17.21B 73.5
SHL $10.79B 19.7
RHC $10.13B 34.8
COH $7.90B 22.9